Harbin Gloria Pharmaceutic (002437.SZ) traded flat 0 % during a 24 hours period ending at 10:57 PM Central Europe on Monday 26th. One Harbin Gloria Pharmaceutic stock can currently be bought for about CNY 3 on popular exchanges. Current supply of Harbin Gloria Pharmaceutic stocks is 2.2 bn. Harbin Gloria Pharmaceutic has a current market capitalization of CNY 6.9 bn and approximately CNY 626.7 mn worth of Harbin Gloria Pharmaceutic was traded on exchanges in the last 24 hours. Since last month end, Harbin Gloria Pharmaceutic has traded -12 % down. Simple moving average of last 200 days is at CNY 3.32. The highest price of past 52 weeks was recorded at CNY 5.1 on 08/18/2026. 52 weeks low was at CNY 2.37 on 06/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Shanghai Qifan Cable Lt (605222.SS) traded flat 0 % and now trades at CNY 19.52. Shanghai Qifan Cable Lt has a market capitalisation of CNY 8.2 bn. Current price/earnings ratio for Shanghai Qifan Cable Lt is 45.71.

  • Wuxi Chipown Micro-electro (688508.SS) traded flat 0 % and now trades at CNY 59.48. Wuxi Chipown Micro-electro has a market capitalisation of CNY 8.2 bn. Wuxi Chipown Micro-electro has a current price to earnings ratio of 91.

  • Shanghai Shunho New Materi (002565.SZ) traded flat 0 % and now trades at CNY 7.57. Shanghai Shunho New Materi has a market capitalisation of CNY 8.2 bn. Current price/earnings ratio for Shanghai Shunho New Materi is 131.99.

  • Efort Intelligent Robot (688165.SS) traded flat 0 % and now trades at CNY 15.6. Current market capitalisation for Efort Intelligent Robot is CNY 8.2 bn.

  • Guangdong Elec Power Dev (200539.SZ) traded flat 0 % and now trades at HKD 1.84. Current market capitalisation for Guangdong Elec Power Dev is HKD 9.7 bn. Current price/earnings ratio for Guangdong Elec Power Dev is 382.12.

About Harbin Gloria Pharmaceutic

Harbin Gloria Pharmaceuticals Co., Ltd is a health care company operating in the pharmaceutical sector. The company, headquartered in Harbin, China, develops and sells various pharmaceutical products. These include cervus and cucumis polypeptide injection, creatine phosphate sodium injection, calcium and zinc gluconates oral solution, and other products. Harbin Gloria Pharmaceuticals markets its products throughout China. The company’s website is accessible under www.gloria.cc , and it is listed on the Shenzhen Stock Exchange. The initial public offering (IPO) for this company took place on June 23, 2010.